A Mayo Clinic case study has found that Botox may offer new hope to patients suffering disabling low cerebrospinal fluid (CSF) headaches. The successful treatment also offers new insight into

This content is restricted to registered user. If you are an existing user, please log in. New users may register for free.

New User Registration
 
 
 
 
 
 
Please indicate that you agree to the Terms of Service *
*Required field